Indraprastha Medical Corporation Ltd
NSE:INDRAMEDCO
Wall Street
Price Targets
INDRAMEDCO Price Targets Summary
Indraprastha Medical Corporation Ltd
According to Wall Street analysts, the average 1-year price target for INDRAMEDCO is 49 INR .
Revenue
Forecast
Revenue Estimate
Indraprastha Medical Corporation Ltd
For the last 8 years the compound annual growth rate for Indraprastha Medical Corporation Ltd's revenue is 6%. The projected CAGR for the next 3 years is -8%.
Operating Income
Forecast
Operating Income Estimate
Indraprastha Medical Corporation Ltd
For the last 8 years the compound annual growth rate for Indraprastha Medical Corporation Ltd's operating income is 9%. The projected CAGR for the next 3 years is -5%.
Net Income
Forecast
Net Income Estimate
Indraprastha Medical Corporation Ltd
For the last 8 years the compound annual growth rate for Indraprastha Medical Corporation Ltd's net income is 13%. The projected CAGR for the next 3 years is -17%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is INDRAMEDCO's stock price target?
Price Target
49
INR
According to Wall Street analysts, the average 1-year price target for INDRAMEDCO is 49 INR .
What is Indraprastha Medical Corporation Ltd's Revenue forecast?
Projected CAGR
-8%
For the last 8 years the compound annual growth rate for Indraprastha Medical Corporation Ltd's revenue is 6%. The projected CAGR for the next 3 years is -8%.
What is Indraprastha Medical Corporation Ltd's Operating Income forecast?
Projected CAGR
-5%
For the last 8 years the compound annual growth rate for Indraprastha Medical Corporation Ltd's operating income is 9%. The projected CAGR for the next 3 years is -5%.
What is Indraprastha Medical Corporation Ltd's Net Income forecast?
Projected CAGR
-17%
For the last 8 years the compound annual growth rate for Indraprastha Medical Corporation Ltd's net income is 13%. The projected CAGR for the next 3 years is -17%.